Glenview Capital Management

GLENVIEW CAPITAL MANAGEMENT, LLC · NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗Activist Investor
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$5.63B2026 Q3+ $498.4M options (notional, not included)
Positions140
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.55.8%

Glenview Capital Management (GLENVIEW CAPITAL MANAGEMENT, LLC) reported 140 positions worth $5.63B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: GPN (9.5%). Biggest move: reduce CVS ($303.9M).

10 / 140 positions shown
#SymbolCompanyValue ↓% Port.Time HeldSharesEst. Buy PriceGain1YYTDSince reported
▸ 1 GPNGlobal Payments$580.3M9.47%6 Years7,105,453$100.07-10.2%——+10.0%
▸ 2 THCTenet Healthcare$523.3M8.54%>10 Years2,047,843$97.49*+199.0%——+14.1%
▸ 3 AMZNAmazon$372.6M6.08%3.8 Years1,495,483$217.93+18.3%——+3.5%
▸ 4 METAMeta Platforms$359.2M5.86%1.8 Years495,268$622.01+0.7%——-13.6%
▸ 5 TMOThermo Fisher Scientific$299.9M4.89%1.5 Years444,245$471.52+46.6%——+2.4%
▸ 6 TEVATeva Pharmaceutical Industries$299.6M4.89%3 Years7,566,877$35.70+19.2%——+7.5%
▸ 7 AAgilent Technologies$257.5M4.20%2 Q1,494,200$121.85+41.9%——+0.4%
▸ 8 IWMPutIshares Tr$255.7M notional4.17%—920,000—————
▸ 9 AMDAdvanced Micro Devices$239.4M3.91%1 Year391,267$290.05+73.9%——-17.6%
▸ 10 DHRDanaher$234.3M3.82%1.5 Years1,057,645$183.81+25.1%——+3.8%

Pro Feature

The remaining 130 positions with Pro.

Upgrade to Pro

Related managers

Five closest superinvestors by Jaccard overlap of tickers held in the latest quarter (computed nightly).

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Glenview Capital Management hold as of Q3 2026?

Glenview Capital Management reported 140 positions worth $5.63B in its Q3 2026 13F filing. Largest positions: GPN (9.5%), THC (8.5%), AMZN (6.1%), META (5.9%) and TMO (4.9%).

What did Glenview Capital Management buy in Q3 2026?

New positions: SGRY, MRVL, ORCL, TXN and RRX (101 in all). Added to: ONTO, HUM, META, TEVA and BRKR (17 in all).

What did Glenview Capital Management sell in Q3 2026?

Reduced: CVS, VTRS, GPN, TMO and A (15 in all). Sold out entirely: DKS, FUN, STM, BKR and ELV (8 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.